Company Filing History:
Years Active: 2014-2016
Title: Thomas Trebing: Innovator in Pharmaceutical Chemistry
Introduction
Thomas Trebing is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, his work focuses on enhancing the efficacy of treatments related to the CCR3 receptor.
Latest Patents
Trebing's latest patents include advancements in co-crystals and salts of CCR3 inhibitors. These inventions relate to pharmaceutical compositions that utilize co-crystals and salts of CCR3 inhibitors of formula 1. The methods developed by Trebing aim to treat and prevent diseases associated with the CCR3 receptor, showcasing his commitment to improving healthcare outcomes.
Career Highlights
Currently, Thomas Trebing is employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves extensive research and development, contributing to the company's mission of delivering innovative healthcare solutions. Trebing's expertise in pharmaceutical chemistry has positioned him as a valuable asset within the organization.
Collaborations
Throughout his career, Trebing has collaborated with esteemed colleagues such as Markus Frank and Hans Haeberle. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the innovation process.
Conclusion
In summary, Thomas Trebing is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of diseases related to the CCR3 receptor. His contributions through patents and collaborations reflect his dedication to improving healthcare solutions.